SFM
COCH icon

Spartan Fund Management’s Envoy Medical COCH Stock Holding History

Spartan Fund Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,205
Closed -$207K – 285
2023
Q2 		$207K Buy
+20,205
New +$204K 0.1% 126
2022
Q4 		– Sell
-68,507
Closed -$673K – 413
2022
Q3 		$673K Hold
68,507
– – 0.2% 188
2022
Q2 		$671K Hold
68,507
– – 0.14% 243
2022
Q1 		$837K Buy
+68,507
New +$667K 0.14% 251

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.67% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Spartan Fund Management's COCH Position: Q3 2023 in Review

Spartan Fund Management sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 20,205 shares — an estimated $207K sold.

Spartan Fund Management first reported a position in COCH in Q1 2022 and held it in 4 quarters. The position peaked at $837K in Q1 2022. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

  • Spartan Fund Management reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
  • Spartan Fund Management sold 20,205 Envoy Medical shares in Q3 2023, an estimated $207K.
  • Spartan Fund Management first reported a position in Envoy Medical in Q1 2022 and held it in 4 quarters.
  • Spartan Fund Management's Envoy Medical position peaked at $837K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on Spartan Fund Management's 13F filing for Q3 2023, filed 23 Oct 2023.